The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Filariasis and lymphoedema
Open accessAbstract
Summary: Among the causes of lymphoedema (LE), secondary LE due to filariasis is the most prevalent. It affects only a minority of the 120 million people infected with the causative organisms of lymphatic filariasis (LF), Wuchereria bancrofti and Brugia malayi/timori, but is clustered in families, indicating a genetic basis for development of this pathology. The majority of infected individuals develop filarial‐specific immunosuppression that starts even before birth in cases where mothers are infected and is characterized by regulatory T‐cell responses and high levels of IgG4, thus tolerating high parasite loads and microfilaraemia. In contrast, individuals with this pathology show stronger immune reactions biased towards Th1, Th2 and probably also Th17. Importantly, as for the aberrant lymph vessel development, innate immune responses that are triggered by the filarial antigen ultimately result in the activation of vascular endothelial growth factors (VEGF), thus promoting lymph vessel hyperplasia as a first step to lymphoedema development. Wolbachia endosymbionts are major inducers of these responses in vitro, and their depletion by doxycycline in LF patients reduces plasma VEGF and soluble VEGF‐receptor‐3 levels to those seen in endemic normals preceding pathology improvement. The search for the immunogenetic basis for LE could lead to the identification of risk factors and thus, to prevention; and has so far led to the identification of single‐nucleotide polymorphisms (SNP) with potential functional relevance to VEGF, cytokine and toll‐like receptor (TLR) genes. Hydrocele, a pathology with some similarity to LE in which both lymph vessel dilation and lymph extravasation are shared sequelae, has been found to be strongly associated with a VEGF‐A SNP known for upregulation of this (lymph‐)angiogenesis factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAVICHANDRAN, M., MAHANTY, S., KUMARASWAMI, V., NUTMAN, T. B., & JAYARAMAN, K. (1997) · Parasite Immunology · doi:10.1046/j.1365-3024.1997.d01-185.x · Cited by 64
Cited by
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tammela, T., & Alitalo, K. (2010) · Cell · doi:10.1016/j.cell.2010.01.045 · Cited by 1,441
Lymphatic filariasis and onchocerciasis
Taylor, M. J., Hoerauf, A., & Bockarie, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60586-7 · Cited by 686
Self-citationThe Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease
Oliver, G., Kipnis, J., Randolph, G. J., & Harvey, N. L. (2020) · Cell · doi:10.1016/j.cell.2020.06.039 · Cited by 679
Helminth infections and host immune regulation
McSorley, H. J., & Maizels, R. M. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05040-11 · Cited by 499
Nanoformulations of Albendazole As Effective Anticancer and Antiparasite Agents
Movahedi, F., Li, L., Gu, W., & Xu, Z. P. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0102 · Cited by 34
Metadata
- Authors
- PFARR, K. M., DEBRAH, A. Y., SPECHT, S., & HOERAUF, A.
- Venue
- Parasite Immunology
- Publisher
- Wiley
- Published
- 2009-10-07
- Volume
- 31
- Issue
- 11
- Pages
- 664-672
- ISSN
- 0141-9838 (ISSN-L)
- 1365-3024
- OpenAlex
- W1618459298
- Cited by
- 163
- References
- 1
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Filariasis and lymphoedema. https://app.cochat.ai/papers/10.1111/j.1365-3024.2009.01133.x
- The paper
- PFARR, K. M., DEBRAH, A. Y., SPECHT, S., & HOERAUF, A. (2009). Filariasis and lymphoedema. Parasite Immunology. https://doi.org/10.1111/j.1365-3024.2009.01133.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.